Chemed (CHE) EBIT (2009 - 2026)

Chemed (CHE) has reported EBIT for 18 consecutive years, with $84.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT fell 10.74% year-over-year to $84.6 million; the TTM figure through Mar 2026 stood at $328.1 million (down 15.65% YoY), while the FY2025 annual figure was $338.2 million, down 7.71% from the prior year.
• EBIT came in at $84.6 million for Q1 2026 at Chemed, down from $100.7 million in the prior quarter.
• The five-year high for EBIT was $113.9 million in Q4 2024, with the low at -$192.9 million in Q4 2022.
• Average EBIT over 5 years is $70.5 million, with a median of $86.8 million recorded in 2023.
• The largest YoY upside for EBIT was 157.74% in 2023 against a maximum downside of 24.4% in 2023.
• Year by year, EBIT stood at -$192.9 million in 2022, then jumped by 157.74% to $111.4 million in 2023, then grew by 2.23% to $113.9 million in 2024, then retreated by 11.61% to $100.7 million in 2025, then fell by 15.97% to $84.6 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $84.6 million, $100.7 million, and $74.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.